2018
DOI: 10.1002/jcp.26622
|View full text |Cite
|
Sign up to set email alerts
|

MiR‐181a inhibits vascular inflammation induced by ox‐LDL via targeting TLR4 in human macrophages

Abstract: Atherosclerosis is a kind of chronic inflammation disease with lipid accumulation in in blood vessel linings. Increasing evidence has reported that microRNAs can exert crucial roles in atherosclerosis. In previous study, miR-181a has been implicated to be abnormally expressed in atherosclerosis mice, however its detailed function in atherosclerosis remains uninvestigated. Hence, in our current study, we focused on the biological role of miR-181a in atherosclerosis progression. Ox-LDL has been commonly identifi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
18
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 28 publications
(19 citation statements)
references
References 35 publications
(40 reference statements)
1
18
0
Order By: Relevance
“…The results turned out to be that miR-181a inhibition diminished MF-triggered promoting effects on cell viability, and repressing effects on the expression of pro-inflammatory cytokines, enzymes, and ROS generation. These observations indicated that miR-181a might perform anti-inflammatory efficacy in LPS-induced ATDC5 cells, which was in line with earlier reports (Xu et al, 2015b;Du and Lu, 2018;Jiang et al, 2018). Combination of our results and previous investigation led to a conclusion demonstrating that MF may have relieved LPS-evoked damaged through upregulating miR-181a expression.…”
Section: Discussionsupporting
confidence: 92%
“…The results turned out to be that miR-181a inhibition diminished MF-triggered promoting effects on cell viability, and repressing effects on the expression of pro-inflammatory cytokines, enzymes, and ROS generation. These observations indicated that miR-181a might perform anti-inflammatory efficacy in LPS-induced ATDC5 cells, which was in line with earlier reports (Xu et al, 2015b;Du and Lu, 2018;Jiang et al, 2018). Combination of our results and previous investigation led to a conclusion demonstrating that MF may have relieved LPS-evoked damaged through upregulating miR-181a expression.…”
Section: Discussionsupporting
confidence: 92%
“…MiRNAs belonging to miR-181 family play a key role in vascular inflammation through regulation of NF-κB signaling, activation of endothelial cells and homeostasis of immune cells [62]. Upregulation of miR-181a in THP-1 cells exposed to oxidated LDL, lipopolysaccharides and phorbol myristate leads to reduction of foam cells formation and inflammatory cytokines levels, lower production of reactive oxygen species and inhibition of apoptosis [63,64]. A higher level of miR-181a in plasma was proposed as a biomarker of myocardial infarction [65].…”
Section: Discussionmentioning
confidence: 99%
“…To differentiate THP-1 monocytes into macrophages, THP-1 monocytes were treated with 10 nM phorbol 12-myristate 13-acetate (Sigma-Aldrich; Merck KGaA) for 48 h (31). Atherosclerotic cell model of macrophages was established as previously described by treating differentiated THP-1 cells with 25 µg/ml ox-LDL for 24 h (31); the significant formation of THP-1 foam cells suggested that the model was successfully established.…”
Section: Methodsmentioning
confidence: 99%